Skip to main content
Industry News
First Ebola treatment approved by FDA
10/15/2020

Regeneron Pharmaceuticals' Inmazeb, a combination of the monoclonal antibodies atoltivimab, maftivimab and odesivimab-ebgn, become the first Ebola treatment to gain FDA approval. The agency approved a vaccine for preventing the virus in December.

Full Story: